Titinopathies

Group of muscular pathologies (skeletal and/or cardiac muscle) caused by a mutation of the titin gene (TTN (2q31.2). Titin or connectin is the largest protein in the human body, and is the most abundant protein in the striated  muscle after myosin  and actin. This elastic protein bound to the myosin filaments is the main constituent of the  longitudinal filaments supporting the myofibrillar architecture. At the A-band level, titin has multiple binding sites with myosin, protein C and AMP deaminase. At the band I level, it is bound to calpain 3. At the Z-band level, its association with actin guarantees the stability of the myofibrillar assembly during the muscle contraction.


More than 127 mutations of the TNT gene, associated with at least 10 different phenotypes (myopathy, cardiomyopathy or both), depending on whether a skeletal and cardiac muscle isoform is affected, were described in 2020. These mutations can lead to dilated or hypertrophic cardiomyopathies, arrhythmogenic right ventricular dysplasia and a dozen of different phenotypes of myopathic phenotypes.


Cardiac involvement:



Muscle involvement (table): a distinction is made between


A.        Forms with congenital or infantile onset: often antenatal onset (fetal immobility, arthrogryposis). In general, motor delay and non-selective muscle weakness, with a relatively diffuse involvement, but a predominantly proximal and axial involvement (paravertebral muscles, diaphragm), and a retractile component (retractions of the Achilles tendons, Rigid Spine) can be present. A primary myocardial involvement (dilated cardiomyopathy) is not always present.



B.        Forms starting after 10 years of age (juvenile) or in adulthood: histology; dystrophy or myofibrillar images



At histologic examination, one can observe, depending on the phenotype: dystrophic lesions, lined vacuoles, cores, nuclear centralization, myofibrillar clusters, eosinophilic inclusions (necklace), a predominance of type 1 fibers, fibers of irregular size.


name

trans
mission

age of onset

phenotype

muscle biopsy

tibial muscular
dystrophy

AD

>35 years

deficit of levator foot muscles

moderate fibrosis

lined vacuoles

early onset tibial muscular dystrophy

AR

20 years

deficit of levator foot muscles

dystrophy

LGMDJ2 or LGMDR10 limb girdle myopathy

AR

<20 years

quickly progressive deficit of the pelvic and scapular girdles

lined vacuoles

hereditary myopathy

with early respiratory

involvement

(HMERF)

AD

(rare AR)

>20 years

distal then

proximo-distal involvement

rapid evolution

Early respiratory involvement

cytoplasmic bodies

Lined vacuoles

Emery Dreifuss-like myopathy

AR

<10 years

limb girdle deficit

early onset of retractions

Rigid Spine

respiratory involvement

cytoplasmic bodies

lined vacuoles

absence of minicores

early myopathy

with lethal cardiac  disease

(EOMFC)

AR

neonatal

moderate motor deficit

ptosis, facial paresis

pseudo-hypertrophy of the calves

severe and early dilated cardiomyopathy

rapid evolution. death

< 20 years

dystrophic aspect

minicores

multiminicores congenital myopathy with cardiomyopathy (MmD with heart disease)

AR

<20 years

predominantly axial deficit

diffuse retractions
with 'rigid spine'

minicores

star-shaped
basophilic deposits

'centronuclear'
myopathy


AR

<20 years

moderate axial and proximal deficit

facial paresis

restrictive syndrome

absence of

cardiomyopathy

central nuclei in most of the muscular fibers


minicores

proximal muscular dystrophy


AR

adulthood

less severe proximal deficit than LGMD2J

dystrophic aspect

LGMD with

cardiomyopathy

AD

adulthood

severe cardiomyopathy

and moderate LGMD

minicores

distal myopathy of

the lower limbs with

posterior predominance

AD

adulthood

distal deficit with

proximal evolution

Involvement of the calves

central nuclei

minicores

arthrogryposis

AR

prenatal

contractures with or without cardiomyopathy



Anesthetic implications: 

echocardiography; check the CPK levels; treatment of heart failure; sometimes implanted automatic defibrillator.

In case of muscle involvement, consider the patient as at risk of rhabdomyolysis induced by the halogenated agents and succinylcholine.


References : 

-        Juntas-Morales R, Perrin A, Cossée M.
Corrélation phénotype-génotype dans les titinopathies.
Cahiers de Myologie 2020; 21: 16-20.

-        Oates EC, Jones KJ, Donkervoort S, Charlton A et al.
Congenital titinopathy : comprehensive characterization  and pathogenic insights.
Ann Neurol 2018 ; 83 : 1105-24

-        Wacker J, Di Bernardo S, Lobrinus JA, et al.
Successful heart transplant in a child with congenital core myopathy and delayed-onset restrictive cardiomyopathy due to recessive mutations in the titin (TTN) gene.
Pediatric Transplantation  2023; e14561. doi:10.1111/

petr.14561


Updated: March 2024